ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,934,000 | +2835.8% | 42,327 | +1782.9% | 0.00% | – |
| Q3 2021 | $134,000 | -73.7% | 2,248 | -69.4% | 0.00% | -100.0% |
| Q1 2021 | $509,000 | -76.3% | 7,339 | -86.7% | 0.00% | -94.7% |
| Q4 2018 | $2,146,000 | -51.0% | 55,092 | -42.1% | 0.02% | -45.7% |
| Q3 2018 | $4,380,000 | +32.4% | 95,180 | +25.4% | 0.04% | +25.0% |
| Q2 2018 | $3,308,000 | -0.8% | 75,877 | -10.1% | 0.03% | -17.6% |
| Q1 2018 | $3,333,000 | -22.3% | 84,370 | -33.2% | 0.03% | +13.3% |
| Q4 2017 | $4,290,000 | +44.2% | 126,285 | +8.2% | 0.03% | +11.1% |
| Q3 2017 | $2,976,000 | +154.1% | 116,692 | +68.2% | 0.03% | +125.0% |
| Q2 2017 | $1,171,000 | – | 69,387 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |